Trifluridina/tipiracilo (TAS-102): Datos clínicos y uso compasivo - page 4

4
Improvement in OS and PFS over time in mCRC
…”There is a life after 1
st
line”
Arnold D. ESMO 2016. Educational session: ‘mCRC: Providing the continuum of care’.
1st line PFS
OS
1,2,3 5,6,7,8,9,10,11,12,13,14,...49
Powered by FlippingBook